Highlander Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$98.4K Sell
5,232
-645
-11% -$11.1K 0.03% 293
2023
Q4
$84.7K Buy
5,877
+5,075
+633% +$69K 0.03% 317
2023
Q3
$14K Buy
802
+730
+1,014% +$15.2K 0.01% 599
2023
Q2
$1K Buy
72
+10
+16% +$217 ﹤0.01% 657
2023
Q1
$1K Sell
62
-5
-7% -$134 ﹤0.01% 639
2022
Q4
$2K Hold
67
﹤0.01% 596
2022
Q3
$2K Hold
67
﹤0.01% 578
2022
Q2
$2K Hold
67
﹤0.01% 590
2022
Q1
$2K Sell
67
-20
-23% -$684 ﹤0.01% 575
2021
Q4
$3K Hold
87
﹤0.01% 549
2021
Q3
$3K Sell
87
-295
-77% -$9.44K ﹤0.01% 547
2021
Q2
$12K Buy
+382
New +$12.6K 0.01% 459

Other funds holding OGN

Highlander Capital Management's OGN Position: Q1 2024 in Review

Highlander Capital Management reduced its Organon & Co (OGN) stake by 11% in Q1 2024, selling an estimated $11.1K and leaving 5,232 shares worth $98.4K. The position accounts for 0.03% of the portfolio, ranked #293.

Highlander Capital Management first reported a position in OGN in Q2 2021 and has held it in 12 quarters since. 719 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Highlander Capital Management held 5,232 shares of Organon & Co worth $98.4K as of Q1 2024.
  • Highlander Capital Management sold 645 Organon & Co shares in Q1 2024, an estimated $11.1K.
  • Organon & Co made up 0.03% of Highlander Capital Management's portfolio in Q1 2024, its #293 holding.
  • Highlander Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 12 quarters since.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.